rct
    2024
    High Quality

    A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

    Unknown authors

    Published in Geroscience

    Key Findings

    Nicotinamide riboside raised blood NAD+ levels but did not significantly improve cognitive or functional outcomes versus placebo.

    Conclusions

    Well-designed null result for NAD+ boosting.

    Supplements Studied

    NMN
    Compound

    Nicotinamide riboside raised blood NAD+ levels but did not significantly improve cognitive or functional outcomes.

    Vitamin B3
    Vitamin

    Nicotinamide riboside raised blood NAD+ levels but did not significantly improve cognitive or functional outcomes versus placebo.

    Outcomes Measured

    ATP Production Enhancement

    Nicotinamide riboside raised blood NAD+ levels but did not significantly improve cognitive or functional outcomes versus placebo.

    Related Health Concerns

    Mild Cognitive Impairment

    Study Details

    Year:2024
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.